<unk>  is indicated to treat attention deficit hyperactivity disorder (ADHD) in people aged six through seventeen. It was previously marketed as an antidepressant for the treatment of major depressive disorder; and is proven to be effective in mild to moderate as well as severe depression with or without co-morbid symptoms. Available forms<unk>  is available for ADHD in the form of 100, 150, and 200 mg extended-release capsules. These capsules can be opened and sprinkled into food for easier administration.
Viloxazine
Indeloxazine
Hydrazoic acid
Cyamemazine
Ridinilazole
Indolocarbazole
Mestilbol
Clocortolone pivalate